House Energy & Commerce Subcommittee Issues Testimony From Yale School of Medicine Fellow (Part 2 of 2)
February 11, 2022
February 11, 2022
WASHINGTON, Feb. 11 -- The House Energy and Commerce Subcommittee on Health issued the following testimony by Reshma Ramachandran, researcher and fellow in the National Clinician Scholars Program at Yale School of Medicine, involving a hybrid hearing on Feb. 3, 2022, entitled "FDA User Fee Reauthorization: Ensuring Safe and Effective Drugs and Biologics".
* * *
(Continued from Part 1 of 2)
The user fee agreements offer several opportunities for Co . . .
* * *
(Continued from Part 1 of 2)
The user fee agreements offer several opportunities for Co . . .